Roy Sturgeon, Ph.D.
Interim Chairman of the Board of Lachman Consultants. Roy began his career at Lachman Consultants as a highly skilled leader of the Compliance Practice. He provides leadership and subject matter expertise for the assessment, analyses, planning, implementation and verification of projects from development to post-marketing surveillance. Dr. Sturgeon develops manufacturing strategies; resolves compliance, formulation and technical manufacturing issues; assesses and renders counsel with respect to vaccine / biological product strategies. Dr. Sturgeon is an expert in crisis management, having handled product withdrawals, and Class I, II, and III recalls, and has served as Corporate Crisis Manager at several large Pharmaceutical Companies. He is proficient in negotiating and responding to global regulatory inspections and in creating detailed plans for remediations. Dr. Sturgeon assesses and evaluates complex development, manufacturing, and compliance issues and analyzes client needs to provide the appropriate regulatory guidance and resources in the manufacture of pharmaceuticals (all dosage forms), biologicals, dietary supplements, vaccines, animal health products, infant formula, devices and diagnostics. He leads efforts for regulatory compliance assessments for M&A projects.